<DOC>
	<DOCNO>NCT00344331</DOCNO>
	<brief_summary>This study evaluate clinical laboratory test might useful determine investigational drug slow progression Niemann-Pick Disease , Type C ( NPC ) , genetic disorder result progressive loss nervous system function . The study : 1 ) look clinical biochemical marker use measure response treatment , 2 ) define rate progression biochemical marker abnormality group NPC patient later invite enroll treatment trial . Patients age NPC may eligible study . Participants undergo follow procedure every 6 month 4- 5-day admission NIH Clinical Center . - Medical evaluation , include medical history , physical exam , neurological exam , neuropsychometric evaluation , blood urine test . - Lumbar puncture ( spinal tap ) : A sample cerebrospinal fluid ( CSF ) , fluid bathe brain spinal cord , obtain study . After administration local anesthetic , small needle inserted space bone low back CSF circulate spinal cord . A small amount fluid collect needle . - Eye exam eye movement study : The pupil eye dilate examine structure eye . For eye movement study special contact lens place eye patient look series target light spot move screen . - Hearing test . - Electroretinography ( patient cooperate test ) measure function retina . Before test , patient 's pupil dilate electrode ( small silver disk ) tap forehead . The patient sits dark room 30 minute special contact lens place one eye numbed drop . The contact lens sense small electrical signal generate retina light flash . During ERG recording , eye stimulate flash light project inside hollow sphere . After test , full eye exam do photograph retina take . - Magnetic resonance imaging ( MRI ) : This test use magnetic field radio wave produce image brain obtain information brain chemical . The patient lie table slide scanner ( narrow cylinder ) , wear earplug muffle loud knock thump sound occur scan process . Patients remain still scanner may sedate test . - Psychometric testing : Patients complete questionnaire . - Photographs patient may take use teaching session scientific presentation publication , patient 's consent . Patients may recognizable , identify name . - Pregnancy test female patient 10 year age begin admission Clinical Center .</brief_summary>
	<brief_title>Evaluation Biochemical Markers Clinical Investigation Niemann-Pick Disease , Type C</brief_title>
	<detailed_description>Niemann-Pick type C disease ( NPC ) autosomal recessive , lysosomal storage disorder characterize accumulation cholesterol gangliosides . NPC rare ( estimate prevalence 1:120,000-150,000 ) neurodegenerative disorder wide clinical spectrum variable age onset . Classically , child NPC demonstrate neurological dysfunction cerebellar ataxia , dysarthria , seizure , vertical gaze palsy , motor impairment , dysphagia , psychotic episode , progressive dementia . In general , adolescent adult onset form insidious onset slow progression . There effective treatment NPC lethal disorder . A major impediment test therapeutic intervention lack well-defined outcome measure . The purpose protocol obtain baseline rate progression data clinical biochemical marker may later use outcome measure clinical trial .</detailed_description>
	<mesh_term>Pick Disease Brain</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Niemann-Pick Diseases</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type A</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type C</mesh_term>
	<criteria>INCLUSION CRITERIA : All patient establish diagnosis NPC ( biochemical molecular ) consider study . Both NPC1 NPC2 patient eligible . Patients age , sex , ethnic background eligible study . EXCLUSION CRITERIA : Patients exclude travel NIH medical condition ill care home . We exclude NPC patient rapidly progressive neonatal cholestasis . Patients exclude pregnant ( negative urine pregnancy test require menstruate female participation study NIH Clinical Center admission ) . Patients exclude MRI section study : 1 . Implanted cardiac pacemaker autodefibrillators 2 . Implanted neural pacemaker 3 . Cochlear implant 4 . Metallic foreign body eye CNS ( CNS aneurysmal clip ) 5 . Any form implant wire metal device may concentrate radio frequency field 6 . Pregnancy ( A negative urine pregnancy test require menstruate female participation study ) 7 . History adverse reaction sedation anesthesia ( sedation necessary ) . 8 . They meet safety criterion establish NIH Clinical Center radiology department MRI scanning . Although priority give patient Zavesca , potential limited number patient , exclusion criterion . Patients Zavesca may exclude future therapeutic trial .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 26, 2017</verification_date>
	<keyword>Lysosomal Storage</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Longitudinal</keyword>
	<keyword>Niemann Pick Type C</keyword>
	<keyword>NPC</keyword>
	<keyword>Lysosomal Storage Disorder</keyword>
</DOC>